Information was received from a consumer regarding a patient receiving clonidine with an unknown concentration for a total dose of 0.5225 mcg/day, bupivacaine with an unknown concentration for a total dose of 9 mg/day, and dilaudid (hydromorphone) with an unknown concentration for a total dose of 4 mg/day via an implantable pump for lumbar radiculopathy.It was reported the patient had two previous manufacturer pumps, but they have been removed and now have a non manufacturer pump.The patient reported with the first pump they got mrsa about 30 days after implant, and it was red.It was stated that the patient just about died.The patient stated that their blood pressure tanked, was burning up and had a temperature of 103 degrees, was septic, and was put on medication through a pic line.It was noted that the patient had to have the pump removed.Event date was noted as (b)(6) 2010.It was noted that the patient no longer has a manufacturer pump, and the situation was resolved.No further complications were reported/anticipated.***there was additional information reported that was not relevant to this event and therefore was omitted;.
|